Development and external validation of a machine learning model for prediction of survival in undifferentiated pleomorphic sarcoma
- 1 September 2023
- journal article
- research article
- Published by Springer Nature in MUSCULOSKELETAL SURGERY
- Vol. 108 (1) , 77-86
Abstract
Purpose Machine learning (ML) algorithms to predict cancer survival have recently been reported for a number of sarcoma subtypes, but none have investigated undifferentiated pleomorphic sarcoma (UPS). ML is a powerful tool that has the potential to better prognosticate UPS. Methods The Surveillance, Epidemiology, and End Results (SEER) database was queried for cases of histologically confirmed undifferentiated pleomorphic sarcoma (UPS) (n = 665). Patient, tumor, and treatment characteristics were recorded, and ML models were developed to predict 1-, 3-, and 5-year survival. The best performing ML model was externally validated using an institutional cohort of UPS patients (n = 151). Results All ML models performed best at the 1-year time point and worst at the 5-year time point. On internal validation within the SEER cohort, the best models had c-statistics of 0.67–0.69 at the 5-year time point. The Multi-Layer Perceptron Neural Network (MLP) model was the best performing model and used for external validation. Similarly, the MLP model performed best at 1-year and worst at 5-year on external validation with c-statistics of 0.85 and 0.81, respectively. The MLP model was well calibrated on external validation. The MLP model has been made publicly available at https://rachar.shinyapps.io/ups_app/. Conclusion Machine learning models perform well for survival prediction in UPS, though this sarcoma subtype may be more difficult to prognosticate than other subtypes. Future studies are needed to further validate the machine learning approach for UPS prognostication.Keywords
This publication has 43 references indexed in Scilit:
- Treating Metastatic Disease: Which Survival Model Is Best Suited for the Clinic?Clinical Orthopaedics and Related Research, 2013
- MissForest—non-parametric missing value imputation for mixed-type dataBioinformatics, 2011
- Chondrosarcoma in the United States (1973 to 2003): An Analysis of 2890 Cases from the SEER DatabaseJournal of Bone and Joint Surgery, 2009
- MFH revisited: outcome after surgical treatment of undifferentiated pleomorphic or not otherwise specified (NOS) sarcomas of the extremities—an analysis of 140 patientsLangenbeck's Archives of Surgery, 2008
- Dedifferentiated chondrosarcoma: Prognostic factors and outcome from a European groupEuropean Journal of Cancer, 2007
- Dedifferentiated central chondrosarcomaCancer, 2006
- Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcomaRadiotherapy and Oncology, 2005
- Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trialThe Lancet, 2002
- Prognostic factors in 227 patients with malignant fibrous histiocytomaCancer, 1992
- Malignant fibrous histiocytoma of soft tissue. A population-based epidemiologic and prognostic study of 137 patientsCancer, 1991